Company Filing History:
1 out of 75 
1 out of 1 
1 out of 5 Years Active: 2017
Title: Thomas Illig: Innovator in Diabetes Research
Introduction
Thomas Illig is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of diabetes research, particularly in identifying biomarkers for type 2 diabetes. His innovative work has the potential to impact the way diabetes is diagnosed and treated.
Latest Patents
Illig holds a patent for a method of identifying a predisposition for developing type 2 diabetes mellitus. This method involves assessing specific metabolites in a sample obtained from a subject. The invention outlines a process for determining the likelihood of developing type 2 diabetes by analyzing the levels of certain metabolites, which can lead to early intervention and prevention strategies.
Career Highlights
Throughout his career, Thomas Illig has worked with prominent research institutions. He has been associated with the Helmholtz Zentrum München, which is known for its research in health and environmental sciences. Additionally, he has contributed to the Deutsche Diabetes-Forschungsgesellschaft, which is a key player in diabetes research in Germany.
Collaborations
Illig has collaborated with esteemed colleagues in the field, including Wolfgang Rathmann and Christian Herder. These partnerships have enhanced his research and contributed to advancements in diabetes diagnostics and treatment.
Conclusion
Thomas Illig's work in identifying biomarkers for type 2 diabetes represents a significant advancement in medical research. His contributions have the potential to improve the lives of many individuals at risk of developing this condition.